Avutometinib and Defactinib in Diffuse Gastric Cancer

Clinical trial NCT06487221 · RECRUITING

Trial details

NCT number: NCT06487221
Sponsor: Ryan H. Moy, MD, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Stomach Cancer

Start date: 2024-10-28
Primary completion: 2028-11-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.